Trial · NCT00346073
Results by group76
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 76
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Seroprotected Subjects With Anti-diphteria (Anti-D) and Anti-tetanus (Anti-T) Antibodies | Boostrix Group | Anti-D | 1418 | Participants | |
| Number of Seroprotected Subjects With Anti-diphteria (Anti-D) and Anti-tetanus (Anti-T) Antibodies | Adacel Group | Anti-D | 717 | Participants | |
| Number of Seroprotected Subjects With Anti-diphteria (Anti-D) and Anti-tetanus (Anti-T) Antibodies | Boostrix Group | Anti-T | 1439 | Participants | |
| Number of Seroprotected Subjects With Anti-diphteria (Anti-D) and Anti-tetanus (Anti-T) Antibodies | Adacel Group | Anti-T | 728 | Participants | |
| Number of Seropositive Subjects With Anti-tetanus (Anti-T) Antibodies | Boostrix Group | 1420 | Participants | ||
| Number of Seropositive Subjects With Anti-tetanus (Anti-T) Antibodies | Adacel Group | 723 | Participants | ||
| Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibody Concentrations | Boostrix Group | Anti-PT | 63.6 | 95% Confidence Interval 60.1 to 67.4 | EL.U/mL |
| Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibody Concentrations | Adacel Group | Anti-PT | 32.2 | 95% Confidence Interval 29.6 to 35.1 | EL.U/mL |
| Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibody Concentrations | Boostrix Group | Anti-FHA | 624.4 | 95% Confidence Interval 593.9 to 656.6 | EL.U/mL |
| Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibody Concentrations | Adacel Group | Anti-FHA | 368.4 | 95% Confidence Interval 344.3 to 394.2 | EL.U/mL |
| Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibody Concentrations | Boostrix Group | Anti-PRN | 401.0 | 95% Confidence Interval 368.5 to 436.3 | EL.U/mL |
| Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibody Concentrations | Adacel Group | Anti-PRN | 351.9 | 95% Confidence Interval 315.7 to 392.2 | EL.U/mL |
| Number of Subjects With Booster Responses for Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibodies | Boostrix Group | Anti-PT | 1095 | Participants | |
| Number of Subjects With Booster Responses for Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibodies | Adacel Group | Anti-PT | 338 | Participants | |
| Number of Subjects With Booster Responses for Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibodies | Boostrix Group | Anti-FHA | 1388 | Participants | |
| Number of Subjects With Booster Responses for Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibodies | Adacel Group | Anti-FHA | 671 | Participants | |
| Number of Subjects With Booster Responses for Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibodies | Boostrix Group | Anti-PRN | 1343 | Participants | |
| Number of Subjects With Booster Responses for Anti-pertussis Toxoid (Anti-PT), Anti-filamentous Hemagglutinin (Anti-FHA) and Anti-pertactin (Anti-PRN) Antibodies | Adacel Group | Anti-PRN | 665 | Participants | |
| Number of Seropositive Subjects With Anti-diphteria (Anti-D) Antibodies | Boostrix Group | 1269 | Participants | ||
| Number of Seropositive Subjects With Anti-diphteria (Anti-D) Antibodies | Adacel Group | 669 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00346073/results